✨ Your Portfolio is fetched and updated from zerodha.
Large Pharmaceuticals
Market Cap
₹95,370 Cr.
P/E
33.25
  • Lupin
  • Dr. Reddy's Lab
  • Zydus Lifesciences
  • TJI Pharma
FAQs on Lupin Ltd. Shareprice

Lupin has given better returns compared to its competitors.
Lupin has grown at ~32.24% over the last 1yrs while peers have grown at a median rate of 13.89%

Lupin is not expensive.
Latest PE of Lupin is 33.25, while 3 year average PE is 57.37.
Also latest EV/EBITDA of Lupin is 19.69 while 3yr average is 33.34.

Growth Table
  • Lupin Ltd.
  • Dr. Reddy's Lab
  • Zydus Lifesciences
Balance Sheet
  • Lupin Ltd.
  • Dr. Reddy's Lab
  • Zydus Lifesciences
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Lupin Ltd.
  • Dr. Reddy's Lab
  • Zydus Lifesciences
Cash Flow
  • Lupin Ltd.
  • Dr. Reddy's Lab
  • Zydus Lifesciences
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Lupin Ltd.
  • Dr. Reddy's Lab
  • Zydus Lifesciences
Quarterly Results
  • Lupin Ltd.
  • Dr. Reddy's Lab
  • Zydus Lifesciences
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Lupin Ltd. Financials

Balance sheet of Lupin is strong.
But short term working capital might become an issue for this company.

Yes, The debt of Lupin is increasing.
Latest debt of Lupin is ₹1,758 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹286 Crs.

Yes, profit is increasing.
The profit of Lupin is ₹2,892 Crs for TTM, ₹1,914 Crs for Mar 2024 and ₹430 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Lupin latest dividend payout ratio is 19.04% and 3yr average dividend payout ratio is 30.68%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Inventory

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech